Hodgson, S.V.
Shirley Hodgson British geneticist
Hodgson, Shirley V.
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
Hodgson, S. V., 1945-
Hodgson, Shirley Victoria
VIAF ID: 82923 (Personal)
Permalink: http://viaf.org/viaf/82923
Preferred Forms
-
200 _ | ‡a Hodgson ‡b S. V.
-
100 1 _ ‡a Hodgson, S. V.
-
100 1 _
‡a
Hodgson, S. V.
-
100 1 _
‡a
Hodgson, S. V.
-
100 1 _
‡a
Hodgson, S. V.
-
100 1 _ ‡a Hodgson, S. V.
-
100 1 _ ‡a Hodgson, S. V., ‡d 1945-
-
100 1 _ ‡a Hodgson, S.V.
-
100 1 _ ‡a Hodgson, Shirley V
-
100 1 _ ‡a Hodgson, Shirley V.
-
100 1 _
‡a
Hodgson, Shirley V.
-
100 1 _
‡a
Hodgson, Shirley V.
-
100 1 _ ‡a Hodgson, Shirley V. (sparse)
-
100 1 _
‡a
Hodgson, Shirley Victoria
-
100 0 _
‡a
Shirley Hodgson
‡c
British geneticist
4xx's: Alternate Name Forms (23)
Works
| Title | Sources |
|---|---|
| Allelic loss at SMAD4 in polyps from juvenile polyposis patients and use of fluorescence in situ hybridization to demonstrate clonal origin of the epithelium |
|
| Association between polymorphisms of the GPX1 gene and second primary tumours after index squamous cell cancer of the head and neck |
|
| Breast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2 |
|
| Cancer genetics services in Europe |
|
| Changes in psychological distress after cancer genetic counselling: a comparison of affected and unaffected women |
|
| A complex endocrine conundrum |
|
| Comprehensive genetic assessment of the ESR1 locus identifies a risk region for endometrial cancer |
|
| Diagnosis and Management of Hereditary Thyroid Cancer |
|
| DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers |
|
| Ethical, social and economic issues in familial breast cancer: a compilation of views from the E.C. Biomed II Demonstration Project |
|
| Exploring the link between MORF4L1 and risk of breast cancer |
|
| Familial breast and ovarian cancer : genetics, screening, and management |
|
| Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk |
|
| Genetic Risk Score Mendelian Randomization Shows that Obesity Measured as Body Mass Index, but not Waist:Hip Ratio, Is Causal for Endometrial Cancer |
|
| Genetic testing and common disorders in a public health framework: how to assess relevance and possibilities. Background Document to the ESHG recommendations on genetic testing and common disorders |
|
| Genome-wide allelotyping of 104 Finnish colorectal cancers reveals an excess of allelic imbalance in chromosome 20q in familial cases |
|
| Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study |
|
| Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer |
|
| Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia |
|
| Germline mutations but not somatic changes at the MYH locus contribute to the pathogenesis of unselected colorectal cancers. |
|
| Guidelines for follow-up of women at high risk for inherited breast cancer: consensus statement from the Biomed 2 Demonstration Programme on Inherited Breast Cancer |
|
| Guidelines for the clinical management of familial adenomatous polyposis (FAP). |
|
| Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers |
|
| Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer |
|
| Identification of a C/G polymorphism in the promoter region of the BRCA1 gene and its use as a marker for rapid detection of promoter deletions |
|
| Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer |
|
| Inherited susceptibility to cancer, 1998: |
|
| Insurance implications for individuals with a high risk of breast and ovarian cancer in Europe |
|
| Large genomic deletions in AIP in pituitary adenoma predisposition. |
|
| Late toxicity is not increased in BRCA1/BRCA2 mutation carriers undergoing breast radiotherapy in the United Kingdom. |
|
| Low prevalence of germline BRCA1 mutations in early onset breast cancer without a family history |
|
| Lymphocyte telomere length is long in BRCA1 and BRCA2 mutation carriers regardless of cancer-affected status |
|
| Mendelian randomization analyses suggest a role for cholesterol in the development of endometrial cancer |
|
| Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1. |
|
| Mutation cluster region, association between germline and somatic mutations and genotype-phenotype correlation in upper gastrointestinal familial adenomatous polyposis |
|
| Mutation-Specific Survival of Inherited Breast Cancer |
|
| Mutations and alternative splicing of theBRCA1 gene in UK breast/ovarian cancer families |
|
| Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome) |
|
| No evidence of RET germline mutations in familial pituitary adenoma. |
|
| No evidence that GATA3 rs570613 SNP modifies breast cancer risk |
|
| An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers |
|
| Peutz-Jeghers disease: most, but not all, families are compatible with linkage to 19p13.3. |
|
| A practical guide to human cancer genetics |
|
| Risk estimation as a decision-making tool for genetic analysis of the breast cancer susceptibility genes. EC Demonstration Project on Familial Breast Cancer |
|
| Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers |
|
| The rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urine |
|
| Screening SMAD1, SMAD2, SMAD3, and SMAD5 for germline mutations in juvenile polyposis syndrome |
|
| Sequence changes in predicted promoter elements of STK11/LKB1 are unlikely to contribute to Peutz-Jeghers syndrome |
|
| Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study |
|
| UBE2QL1 is disrupted by a constitutional translocation associated with renal tumor predisposition and is a novel candidate renal tumor suppressor gene |
|
| Utilisation of prophylactic mastectomy in 10 European centres |
|
| What motivates interest in attending a familial cancer genetics clinic? |
|
| Whole-gene APC deletions cause classical familial adenomatous polyposis, but not attenuated polyposis or "multiple" colorectal adenomas |
|
